GAMMA Investing’s Lyell Immunopharma LYEL Stock Holding History

GAMMA Investing’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492	Hold	35	–	–	﹤0.01%	3986
2026 Q1	$702	Hold	35	–	–	﹤0.01%	3899
2025 Q4	$1.08K	Hold	35	–	–	﹤0.01%	3768
2025 Q3	$568	Hold	35	–	–	﹤0.01%	3697
2025 Q2	$309	Buy	+35	New	+$319	﹤0.01%	3690

Other funds holding LYEL

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

GAMMA Investing's LYEL Position: Q2 2026 in Review

GAMMA Investing held its Lyell Immunopharma (LYEL) position steady in Q2 2026 at 35 shares worth $492. The position accounts for ﹤0.01% of the portfolio, ranked #3986.

GAMMA Investing first reported a position in LYEL in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.08K in Q4 2025. 7 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

GAMMA Investing held 35 shares of Lyell Immunopharma worth $492 as of Q2 2026.
GAMMA Investing left its Lyell Immunopharma share count unchanged in Q2 2026.
Lyell Immunopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3986 holding.
GAMMA Investing first reported a position in Lyell Immunopharma in Q2 2025 and has held it in 5 quarters since.
GAMMA Investing's Lyell Immunopharma position peaked at $1.08K in Q4 2025.
7 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.